Category: Philips HealthcareSyndicate content

Smith & Nephew plans to reveal new strategy for mature markets | Medtech Wall Street news for the week of July 28, 2014

July 31, 2014 by MassDevice

Here's a look at some of the top Wall Street stories for medical device companies this week: Smith & Nephew CEO reveals new 'no frills' strategy; Bard: We're on track for early 2015 Lutonix approval; Ocular Therapeutix prices IPO below range; Philips' healthcare business suffers in Q2; Intersect ENT prices IPO at low end of range

Smith & Nephew CEO reveals new 'no frills' strategy

July 28, 2014 by Brad Perriello

Philips' healthcare business suffers in Q2

July 28, 2014 by Arezu Sarvestani

Sluggish healthcare sales drag down Philips overall figures, but the company is eying a comeback for the 2nd half of the year.

Philips' healthcare business suffers in Q2

Philips Healthcare (NYSE:PHG) had a tough 2nd quarter with a shutdown of a manufacturing facility in Cleveland taking some of the wind out of the sales for the entire company.

Ex-Neuronetics, Abiomed exec is Intact Vascular's new CEO | Personnel Moves

July 15, 2014 by Brad Perriello

Bruce Shook, the co-founder & former CEO of Neuronetics and the ex-president of Abiomed, is named CEO of Intact Vascular.

Ex-Neuronetics, Abiomed exec is Intact Vascular's new CEO | Personnel Moves

Intact Vascular said yesterday that it named medical device veteran Bruce Shook as its new president & CEO.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

FDA chides Philips Respironics over infant sleep monitor manufacturing

July 14, 2014 by Arezu Sarvestani

FDA inspectors say that Philips cut corners at a manufacturing facility that makes infant sleep apnea devices that were recalled due to battery issues.

FDA chides Philips on manufacturing issues

Philips Healthcare's (NYSE:PHG) Respironics unit is in the FDA's cross-hairs after regulators inspected a manufacturing facility responsible for infant sleep apnea monitors that were the subject of a recall.

T2 Biosystems prepares to go public in an offering that could garner $69 million | Medtech Wall Street news for the week of July 7, 2014

July 10, 2014 by MassDevice

Here's a look at some of the top Wall Street stories for medical device companies this week: T2 Biosystems prepares $69M IPO for MRI-based diagnostics; Philips Healthcare retools, CEO DiSanzo is out; iRadimed sets terms for $10M IPO

T2 Biosystems prepares $69M IPO for MRI-based diagnostics

July 2, 2014 by Arezu Sarvestani

T2 Biosystems prepares to go IPO

Philips Healthcare retools, CEO DiSanzo is out

July 8, 2014 by Brad Perriello

Philips Healthcare CEO Deborah DiSanzo is out as the Dutch conglomerate retools after reporting lower-than-expected 2nd-quarter earnings for its healthcare business.

Philips Healthcare retools, CEO DiSanzo is out

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp